Which hedge funds own SNDX? SYNDAX PHARMACEUTICALS INC, Q2 2026 13F holders
53 tracked hedge funds disclosed a position in SNDX (SYNDAX PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $990.5m in total. The largest holder by portfolio weight is Elmind Capital, LP at 10.2% of its book. 11 opened a new position this quarter: Jones Hill Capital LP, Seven Fleet Capital Management LP, Y-Intercept (Hong Kong) Ltd, Arrowpoint Investment Partners (Singapore) Pte. Ltd.. 14 exited: Stempoint Capital LP, Integral Health Asset Management, LLC, Cinctive Capital Management LP.
- 53
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 11
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 14
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $36.5m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $95.6m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $990m
- Combined value Sum of the holders' reported positions in the security.
- 4.3%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Stempoint Capital LP | 5.5% | $28.4m |
| Integral Health Asset Management, LLC | 0.4% | $8.2m |
| Cinctive Capital Management LP | 0.2% | $2.7m |
| Fox Run Management, L.L.C. | 0.09% | $494k |
| Point72 Asset Management, L.P. | 0.08% | $46.4m |
| Clearline Capital LP | 0.08% | $1.0m |
| ADAR1 Capital Management, LLC | 0.02% | $409k |
| ExodusPoint Capital Management, LP | 0.02% | $2.5m |
| Voleon Capital Management LP | 0.02% | $856k |
| Hudson Bay Capital Management LP | 0.01% | $1.5m |
| Tudor Investment Corp ET AL | 0.01% | $1.6m |
| Quantbot Technologies LP | 0.0% | $54.9k |
| Farallon Capital Management, L.L.C. | 0.0% | $234k |
| Marshall Wace, LLP | 0.0% | $1.3m |
Ownership over time
Who discovered SNDX first? Beta
The run: Q1 2019 → Q4 2022, +385%
| 683 Capital Management, LLC | Q1 2019 | 1.1% | +2.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.